pcmr12105-sup-0001-DataS1.docWord document38KData S1. Materials and methods.
pcmr12105-sup-0002-FigureS1.tifimage/tif3414KFigure S1. (A) Human CD4+ and CD8+ T-cell subsets identified by FACS analysis (representative FACS plots for CD4+ and CD8+ T-cells). (B) Characterization of human Treg (CD4+CD25hiFoxP3+) population by FACS analysis (representative FACS plots for Treg (CD4+CD25hiFoxP3+) cells).
pcmr12105-sup-0003-FigureS2.tifimage/tif2579KFigure S2. CD4+ and CD8+ T-cell counts and CD4+/CD8+ ratio in male and female patients with GV.
pcmr12105-sup-0004-FigureS3.tifimage/tif3677KFigure S3. Back gating strategy for CD4+CD25hiFoxP3+ regulatory T cells (Tregs).
pcmr12105-sup-0005-FigureS4.tifimage/tif4714KFigure S4. CD4+CD25hiFoxP3+ regulatory T cells (Tregs) in healthy controls.
pcmr12105-sup-0006-TableS1-S2.docWord document42K

Table S1. Demographic characteristics of generalized vitiligo (GV) patients and unaffected controls.

Table S2. Counts of CD4+ and CD8+ T cells and CD4+ /CD8+ ratio with respect to age of onset of generalized vitiligo (GV).

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.